Compounds for use as iron (III) MRI contrast agents containing anionic pendents and ancillary groups

US11344635B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11344635-B2
Application numberUS-201916973349-A
CountryUS
Kind codeB2
Filing dateNov 18, 2019
Priority dateNov 16, 2018
Publication dateMay 31, 2022
Grant dateMay 31, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Macrocyclic complexes and macrocyclic compounds. The macrocyclic complexes or macrocyclic compounds have a TACN moiety with one or more amine group(s) or a O- or S-substituted TACN moiety. The macrocyclic complexes have a high-spin Fe(III) atom coordinated to the TACN moiety. The macrocyclic complexes can be used in imaging methods.

First claim

Opening claim text (preview).

The invention claimed is: 1. A macrocyclic complex comprising: a 1,4,7-triazacyclononane (TACN) moiety or an O-substituted TACN moiety having a structure: wherein R 1 , Z 1 , Z 2 , and Z 3 are anionic pendent groups independently chosen from: deprotonated analogs thereof, and combinations thereof, wherein R 3 is a substituted or unsubstituted alkyl or a substituted or unsubstituted aryl group and R 4 is a substituted alkyl or unsubstituted alkyl or a substituted or unsubstituted aryl group; and a high-spin Fe(III) cation complexed to the TACN moiety and at least one anionic pendent group substituent of the TACN moiety, or a high-spin Fe(III) cation complexed to the O-substituted TACN moiety and at least one anionic pendent group substituent of the O-substituted TACN moiety, wherein: when the macrocyclic complex is: Z 1 and Z 2 are and Z 3 is not and when the macrocyclic complex is: Z 1 and Z 2 are wherein R 4 is an unsubstituted aryl, and Z 3 is not wherein R 4 is an unsubstituted aryl. 2. The macrocyclic complex of claim 1 , wherein at least one or all of the one or more pendent groups is covalently bound to a nitrogen atom on the TACN moiety or an O-substituted TACN moiety. 3. The macrocyclic complex of claim 1 , wherein the macrocyclic complex has at least one open coordination site. 4. The macrocyclic complex of claim 1 , wherein the macrocyclic complex has at least one water complexed to the high-spin Fe(III) cation. 5. A macrocyclic complex comprising: a 1,4,7-triazacyclononane (TACN) moiety having a structure: wherein Z 1 and Z 2 are anionic pendent groups independently chosen from: deprotonated analogs thereof, and combinations thereof, R 1 is an anionic pendent groups independently chosen from: deprotonated analogs thereof, and combinations thereof, wherein R 2 is a substituted or unsubstituted alkyl group, a substituted or unsubstituted aromatic group or a substituted ether; R 3 is a substituted or unsubstituted alkyl or a substituted or unsubstituted aryl group; R 4 is a substituted alkyl or unsubstituted alkyl or a substituted or unsubstituted aryl group; and Q 1 is aryl substituted with an anionic group, an alkyl group substituted with an anionic group or an aralkyl group substituted with an anionic group; and a high-spin Fe(III) cation complexed to the TACN moiety and at least one anionic pendent group substituent of the TACN moiety. 6. The macrocyclic complex of claim 5 , wherein at least one or all of the one or more pendent groups is covalently bound to a nitrogen atom on the TACN moiety. 7. The macrocyclic complex of claim 5 , wherein the macrocyclic complex has at least one open coordination site. 8. The macrocyclic complex of claim 5 , wherein the macrocyclic complex has at least one water and/or at least one hydroxide complexed to the high-spin Fe(III) cation.

Assignees

Inventors

Classifications

  • C07F19/00Primary

    Metal compounds according to more than one of main groups C07F1/00 - C07F17/00 · CPC title

  • having three nitrogen atoms as the only ring hetero atoms · CPC title

  • without a metal-carbon linkage · CPC title

  • each of the hetero rings containing nitrogen as ring hetero atom · CPC title

  • A61K49/106Primary

    the complex-forming compound being cyclic, e.g. DOTA · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11344635B2 cover?
Macrocyclic complexes and macrocyclic compounds. The macrocyclic complexes or macrocyclic compounds have a TACN moiety with one or more amine group(s) or a O- or S-substituted TACN moiety. The macrocyclic complexes have a high-spin Fe(III) atom coordinated to the TACN moiety. The macrocyclic complexes can be used in imaging methods.
Who is the assignee on this patent?
Univ New York State Res Found
What technology area does this patent fall under?
Primary CPC classification C07F19/00. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue May 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).